<DOC>
	<DOCNO>NCT02360917</DOCNO>
	<brief_summary>At Cedars-Sinai Medical Center , develop novel curriculum 6-week psycho-educationally-based , cognitive behavioral program help patient subjective cognitive complaint cancer treatment , title Emerging Haze™ ( Haze ) . Each series meet week 2 hour 6 week . The lead neuropsychologist cover material guide relaxation , behavioral strategy automatic/negative thought , compensatory strategy attention memory , executive functioning , pace , balance . Each Haze series electronically deliver live format satellite site , The University Kansas .</brief_summary>
	<brief_title>Emerging From Haze™- Measuring Impact Psycho-education Program Perceived Cognition After Breast Cancer Treatment</brief_title>
	<detailed_description />
	<criteria>Completed treatment stage 13 breast cancer least two month 24 month prior enrollment . Having receive chemotherapy without radiation therapy Female , Age ≥18 year . FACTCog score less 59 Perceived Cognitive Impairment subscale Eligible 2 month complete active cancer treatment exception longterm hormonal treatment trastuzumab . Subjective complaint cognitive concern time enrollment Must able understand communicate proficiently English Ability understand willingness sign write informed consent . Agree complete study survey Patients significant personality disorder unstable psychiatric disorder ( include active major depression , substance abuse , psychosis bipolar disorder ) assess interview clinician Patients know brain metastasis , history brain metastasis radiation brain . Patients history stroke preexist neurological condition may contribute cognitive dysfunction . NonEnglish speaker Receiving treatment another malignancy breast cancer Uncontrolled intercurrent illness include , limited , ongoing active infection , chronic anemia , uncontrolled hypothyroidism , symptomatic congestive heart failure , unstable angina pectoris , uncontrolled cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cognitive Dysfunction</keyword>
	<keyword>Cancer Survivorship</keyword>
</DOC>